ImmunoPharmaceuticals: 1st Edition (Hardback) book cover


1st Edition

Edited by Edward S. Kimball

CRC Press

288 pages

Purchasing Options:$ = USD
Hardback: 9780849383885
pub: 1995-11-27
SAVE ~$64.00
Currently out of stock

FREE Standard Shipping!


Written by a leading researcher in immunology, ImmunoPharmaceuticals specifically focuses on immunologically active drugs recently tested for clinical activity or recently approved for medical use. Each chapter focuses on a single drug or class of drugs and discusses data from basic and preclinical research concerning mechanisms of action. Preclinical models are compared with clinical findings to allow the reader to evaluate the predictive value of those models. Featured drugs are being studied for therapy of cancer, arthritic disease, autoimmune disease, immunodeficiency disease, transplantation, and determination of sepsis. Overviews of the retinoids in cancer therapy and preclinical studies on flavonoids are featured.

Table of Contents

FK-506: Pre-Clinical and Clinical Studies, W.H. Parsons and N.H. Sigal

Rapamycin (Sirolimus, Rapamune ™): A Novel Immunosuppressive Agent, K.L. Molnar-Kimber and S. N. Sehgal

Deoxyspergualin for Immune Suppression, M.A. Tepper and S.L. Kelley

Retinoids in Cancer, R. Warrell

Bestatin for Anti-Cancer Treatments, J.E. Talmadge, K. Ino, and P.J. Bierman

Synthetic Guanine Ribonucleosides as Immunostimulants, B.L. Pope and M.G. Goodman

Radioimmunopharmaceuticals for Immunodiagnostic Imaging, H.F. Solomon

The Flavonoids as Potential Therapeutic Targets, E. Middleton, Jr.


About the Series

Handbooks in Pharmacology and Toxicology

Learn more…

Subject Categories

BISAC Subject Codes/Headings:
MEDICAL / Immunology
MEDICAL / Pharmacology